These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38135862)

  • 1. Predicting the Addition of Information Regarding Clinically Significant Adverse Drug Reactions to Japanese Drug Package Inserts Using a Machine-Learning Model.
    Watanabe T; Ambe K; Tohkin M
    Ther Innov Regul Sci; 2024 Mar; 58(2):357-367. PubMed ID: 38135862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streamlining Considerations for Safety Measures: A Predictive Model for Addition of Clinically Significant Adverse Reactions to Japanese Drug Package Inserts.
    Watanabe T; Ambe K; Tohkin M
    Biol Pharm Bull; 2024; 47(3):611-619. PubMed ID: 38479885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between concerns toward adverse reactions during pre-approval drug reviews and the post-approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre-approval drug review reports and safety updates.
    Watanabe K; Murakami M; Masuyama K; Ishiguro C; Matsuda T
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1265-1276. PubMed ID: 30252199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.
    Li X; Lin X; Ren H; Guo J
    J Med Internet Res; 2020 Jul; 22(7):e20443. PubMed ID: 32706718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post-approval in Japan.
    Saito R; Miyazaki S
    Pharmacol Res Perspect; 2023 Aug; 11(4):e01110. PubMed ID: 37365794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to addition.
    Tamura N; Ishiguro C; Matsuda T
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):166-75. PubMed ID: 24737526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics on Drug Safety Measures in Japan Stratified by System Organ Classes and Therapeutic Categories in Relation to the Approval Date.
    Hiramatsu A; Hanaoka H; Uyama Y
    Ther Innov Regul Sci; 2020 Nov; 54(6):1534-1540. PubMed ID: 32524501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels.
    Tiftikci M; Özgür A; He Y; Hur J
    BMC Bioinformatics; 2019 Dec; 20(Suppl 21):707. PubMed ID: 31865904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.
    Liu M; Wu Y; Chen Y; Sun J; Zhao Z; Chen XW; Matheny ME; Xu H
    J Am Med Inform Assoc; 2012 Jun; 19(e1):e28-35. PubMed ID: 22718037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning for Predicting Hyperglycemic Cases Induced by PD-1/PD-L1 Inhibitors.
    Yang J; Li N; Lin W; Shi L; Deng M; Tong Q; Yang W
    J Healthc Eng; 2022; 2022():6278854. PubMed ID: 36032541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System.
    Suzuki S; Imai S; Mitsuboshi S; Kizaki H; Hashiguchi M; Hori S
    J Clin Pharmacol; 2023 Aug; 63(8):903-908. PubMed ID: 37042319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Machine-learning Algorithms Predict Early Revision TKA in the Danish Knee Arthroplasty Registry?
    El-Galaly A; Grazal C; Kappel A; Nielsen PT; Jensen SL; Forsberg JA
    Clin Orthop Relat Res; 2020 Sep; 478(9):2088-2101. PubMed ID: 32667760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events caused by drug interactions involving glucuronoconjugates of zidovudine, valproic acid and lamotrigine, and analysis of how such potential events are discussed in package inserts of Japan, UK and USA.
    Hirata-Koizumi M; Saito M; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2007 Apr; 32(2):177-85. PubMed ID: 17381668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.
    Song D; Chen Y; Min Q; Sun Q; Ye K; Zhou C; Yuan S; Sun Z; Liao J
    J Clin Pharm Ther; 2019 Apr; 44(2):268-275. PubMed ID: 30565313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning model combining features from algorithms with different analytical methodologies to detect laboratory-event-related adverse drug reaction signals.
    Jeong E; Park N; Choi Y; Park RW; Yoon D
    PLoS One; 2018; 13(11):e0207749. PubMed ID: 30462745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multivariate prediction model to identify individual case safety reports which require clinical review.
    Gosselt HR; Bazelmans EA; Lieber T; van Hunsel FPAM; Härmark L
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1300-1307. PubMed ID: 36251280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Develop an ADR prediction system of Chinese herbal injections containing Panax notoginseng saponin: a nested case-control study using machine learning.
    Wu XW; Zhang JY; Chang H; Song XW; Wen YL; Long EW; Tong RS
    BMJ Open; 2022 Sep; 12(9):e061457. PubMed ID: 36691200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts.
    Cocos A; Fiks AG; Masino AJ
    J Am Med Inform Assoc; 2017 Jul; 24(4):813-821. PubMed ID: 28339747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Expression Data Based Deep Learning Model for Accurate Prediction of Drug-Induced Liver Injury in Advance.
    Feng C; Chen H; Yuan X; Sun M; Chu K; Liu H; Rui M
    J Chem Inf Model; 2019 Jul; 59(7):3240-3250. PubMed ID: 31188585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.